Market Overview The global asthma and COPD drugs market is experiencing growth driven by respiratory disease prevalence, treatment innovation, and disease management focus. The asthma and COPD drugs market is projected to exceed USD 32.4 billion through 2030, fueled by patients exceeding 500 million globally, disease severity, and treatment options. Respiratory therapeutics represent essential...